Advanced Accelerator Application, Inc., a Novartis Company



At Advanced Accelerator Applications (AAA), we are reimagining nuclear medicine and cancer care. Our mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and precision imaging radioligands for oncology.

Founded in 2002, AAA has a strong legacy as a pioneer in nuclear medicine. We believe targeted radioligand therapy has the potential to be broadly used in many different tumor types.

Contact details

Products & Services

Documents & Links